R&D and manufacturing of vaccines for COVID-19

Sunil Mani

Chapter 3 in India’s High-Tech Leap, Industrial Policy and Future of Innovation, 2026, pp 50-93 from Edward Elgar Publishing

Abstract: This chapter focuses on India's role as a major global vaccine producer, particularly during the COVID-19 pandemic. It examines the challenges faced in scaling up production during the crisis and the importance of state intervention in public health innovation. The chapter discusses the lessons learned from this experience and how India can better position itself to respond to future public health challenges through robust frameworks for collaboration and innovation in health-focused high-technology sectors.

Keywords: Vaccine Manufacturing; Public Health Innovation; Covid-19; Global Value Chains; State Intervention; Technology Transfer (search for similar items in EconPapers)
Date: 2026
ISBN: 9781035382309
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/doi/10.4337/9781035382316.00009 (application/pdf)
Our link check indicates that this URL is bad, the error code is: 403 Forbidden

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:25180_3

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Jack Sweeney ().